Cormedix (AMEX:CRMD) and has gained 5.58% or nine cents a share to settle at $1.70 with a volume of 7500 shares, compared to its average three-month volume of 20,000 shares. For the past 52 weeks the stock has been trading between $.40 a share and $4.00 a share with a current market capitalization of $19.39 million.
CorMedix, Inc., a development-stage biopharmaceutical company, develops, manufactures, and markets products that lock a patient's central venous catheter between hemodialysis sessions to keep it free of infection and clots.
Celsion Corporation (NASDAQ:CLSN) has lost 1.14% or three cents a share to settle at $2.43 with a volume of 100,000 shares, compared to its average three-month volume of 128,000 shares. For the past 52 weeks the stock has been trading between $1.98 and $5.63 with a current market capitalization of $31 million.
Celsion Corporation (Celsion) is an oncology drug development company focused on improving treatment for those suffering with aggressive and difficult to treat forms of cancer. Its lead product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer and a Phase II study for recurrent chest wall breast cancer. ThermoDox is a liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a range of cancers.
Windstream (NASDAQ:WIN) has lost 0.62% or eight cents a share to settle at $12.39 with a volume of 4.3 million shares, compared to its average three-month volume of 5.5 million shares. For the past 52 weeks the stock has been trading between $6.02 and $14.40 with a current market capitalization of $6.25 billion and a trailing 12 months P/E ratio of 18.85.
Windstream Corporation (Windstream) is a telecommunications company that provides phone, high-speed Internet and digital television services. It also offers a range of Internet protocol-based (IP) voice and data services and phone systems and equipment to businesses and government agencies. As of December 31, 2009, it provided service to approximately 3 million access lines and 1.1 million high-speed Internet customers primarily located in rural areas in 16 states.
Cytori Therapeutics (NASDAQ:CYTX) has surged 11.41% or $.64 a share to settle at $6.25 with a volume of 2.2 million shares traded, compared to its average three-month volume of 415,000 shares. For the past 52 weeks the stock has been trading between $3.15 and $7.76 with a current market capitalization of $315 million.
Cytori Therapeutics, Inc. develops, manufactures, and sells medical products and devices to enable the practice of regenerative medicine. The Company's technology is the Celuion family of products, which processes patients' adipose-derived stem and regenerative cells (ADRCs) at the point of care. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, enzymes, and related instrumentation.
Vista Gold (AMEX:VGZ) has gained 4.55% or $.16 to settle at $3.68 a share with a volume of 1.9 million shares compared to its average three-month volume of 649,000 shares. For the past 52 weeks the stock has been trading between $1.30 and $3.90 with a current market capitalization of $171 million.
Vista Gold Corp. is engaged in the evaluation, acquisition, exploration and advancement of gold exploration and development projects. The Company's holdings include the Paredones Amarillos project in Mexico; the Mt. Todd gold mine in Australia; the Guadalupe de los Reyes project in Mexico; the Yellow Pine project in Idaho; the Awak Mas project in Indonesia; the Long Valley project in California, and mining claims in Utah.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: PennyTrader.com has not been compensated for any stocks listed in this stock news report.
Triple Volatility Triple the Fun: CRMD, CLSN, WIN, CYTX, VGZ